MERCK & CO. INC. (6MK.DE) Stock Price & Overview
FRA:6MK • US58933Y1055
Current stock price
The current stock price of 6MK.DE is 103.62 EUR. Today 6MK.DE is down by -1.09%. In the past month the price increased by 3.11%. In the past year, price increased by 52.71%.
6MK.DE Key Statistics
- Market Cap
- 256.189B
- P/E
- 13.18
- Fwd P/E
- 23.40
- EPS (TTM)
- 7.86
- Dividend Yield
- 2.84%
6MK.DE Stock Performance
6MK.DE Stock Chart
6MK.DE Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to 6MK.DE. When comparing the yearly performance of all stocks, 6MK.DE is one of the better performing stocks in the market, outperforming 88.23% of all stocks.
6MK.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to 6MK.DE. 6MK.DE has an excellent profitability rating, but there are some minor concerns on its financial health.
6MK.DE Earnings
On February 3, 2026 6MK.DE reported an EPS of 2.09 and a revenue of 16.40B. The company beat EPS expectations (2.98% surprise) and beat revenue expectations (0.31% surprise).
6MK.DE Forecast & Estimates
35 analysts have analysed 6MK.DE and the average price target is 108.2 EUR. This implies a price increase of 4.42% is expected in the next year compared to the current price of 103.62.
For the next year, analysts expect an EPS growth of -43.62% and a revenue growth 3.06% for 6MK.DE
6MK.DE Groups
Sector & Classification
6MK.DE Financial Highlights
Over the last trailing twelve months 6MK.DE reported a non-GAAP Earnings per Share(EPS) of 7.86. The EPS increased by 20.16% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 28.08% | ||
| ROA | 13.34% | ||
| ROE | 34.7% | ||
| Debt/Equity | 0.89 |
6MK.DE Ownership
6MK.DE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| SAN | SANOFI | 9.46 | 98.09B | ||
| 1SAN | SANOFI | 9.5 | 97.617B | ||
| SNW | SANOFI | 9.49 | 97.52B | ||
| UCB | UCB SA | 26.74 | 52.868B | ||
| UNC | UCB SA | 25.9 | 51.818B | ||
| MRK | MERCK KGAA | 13.53 | 48.435B | ||
| 1MRK | MERCK KGAA | 12.99 | 46.695B | ||
| 1BAYN | BAYER AG-REG | 8.66 | 39.808B | ||
| BAYN | BAYER AG-REG | 8.57 | 39.739B | ||
| IPN | IPSEN | 14 | 13.636B | ||
| REC | RECORDATI INDUSTRIA CHIMICA | 17.04 | 10.185B | ||
| TUB | FINANCIERE DE TUBIZE | N/A | 9.908B | ||
| VIRP | VIRBAC SA | 16.72 | 2.978B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About 6MK.DE
Company Profile
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company is headquartered in Rahway, New Jersey and currently employs 75,000 full-time employees. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The firm sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. The company sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.
Company Info
IPO: 1941-01-01
MERCK & CO. INC.
126 East Lincoln Avenue, P.O. Box 2000
Rahway NEW JERSEY US
Employees: 75000
Phone: 19087404000
MERCK & CO. INC. / 6MK.DE FAQ
Can you describe the business of MERCK & CO. INC.?
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company is headquartered in Rahway, New Jersey and currently employs 75,000 full-time employees. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The firm sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. The company sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.
Can you provide the latest stock price for MERCK & CO. INC.?
The current stock price of 6MK.DE is 103.62 EUR. The price decreased by -1.09% in the last trading session.
Does MERCK & CO. INC. pay dividends?
MERCK & CO. INC. (6MK.DE) has a dividend yield of 2.84%. The yearly dividend amount is currently 2.84.
How is the ChartMill rating for MERCK & CO. INC.?
6MK.DE has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
Can you provide the growth outlook for MERCK & CO. INC.?
The Revenue of MERCK & CO. INC. (6MK.DE) is expected to grow by 3.06% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the number of employees for MERCK & CO. INC.?
MERCK & CO. INC. (6MK.DE) currently has 75000 employees.
What is the next earnings date for 6MK stock?
MERCK & CO. INC. (6MK.DE) will report earnings on 2026-04-30.